Jacobs Levy Equity Management Inc. Grows Position in Molina Healthcare, Inc. (NYSE:MOH)

Jacobs Levy Equity Management Inc. raised its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 6.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 537,057 shares of the company's stock after purchasing an additional 32,273 shares during the period. Jacobs Levy Equity Management Inc. owned 0.94% of Molina Healthcare worth $156,310,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Colonial Trust Co SC raised its position in shares of Molina Healthcare by 930.0% in the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after acquiring an additional 93 shares in the last quarter. Wingate Wealth Advisors Inc. bought a new position in shares of Molina Healthcare in the 4th quarter worth approximately $52,000. Hurley Capital LLC bought a new position in shares of Molina Healthcare in the 4th quarter worth approximately $55,000. EverSource Wealth Advisors LLC raised its position in shares of Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after acquiring an additional 88 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd raised its position in shares of Molina Healthcare by 895.0% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after acquiring an additional 179 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MOH. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Guggenheim started coverage on Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Finally, Sanford C. Bernstein started coverage on Molina Healthcare in a report on Tuesday, April 22nd. They set an "outperform" rating and a $414.00 price target on the stock. Nine research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Molina Healthcare presently has a consensus rating of "Hold" and a consensus price target of $365.38.

Molina Healthcare Stock Performance

Shares of NYSE MOH traded up $1.06 during trading on Wednesday, hitting $311.51. The company had a trading volume of 582,465 shares, compared to its average volume of 684,506. The stock has a 50 day simple moving average of $324.46 and a 200 day simple moving average of $308.43. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. Molina Healthcare, Inc. has a 12 month low of $262.32 and a 12 month high of $365.23. The firm has a market capitalization of $16.88 billion, a P/E ratio of 15.25, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The firm had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. During the same quarter last year, the company earned $5.73 earnings per share. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now owns 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at $82,484,262.90. This represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 89,169 shares of company stock worth $28,520,995. 1.10% of the stock is owned by corporate insiders.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.